Open Access

[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2

  • Authors:
    • Faqing Tian
    • Yong Zhan
    • Wei Zhu
    • Juheng Li
    • Meiqin Tang
    • Xiaohui Chen
    • Jian Jiang
  • View Affiliations

  • Published online on: August 2, 2019     https://doi.org/10.3892/ijmm.2019.4297
  • Pages: 1594-1594
  • Copyright : © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October 2019
Volume 44 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Tian, F., Zhan, Y., Zhu, W., Li, J., Tang, M., Chen, X., & Jiang, J. (2019). [Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2. International Journal of Molecular Medicine, 44, 1594-1594. https://doi.org/10.3892/ijmm.2019.4297
MLA
Tian, F., Zhan, Y., Zhu, W., Li, J., Tang, M., Chen, X., Jiang, J."[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2". International Journal of Molecular Medicine 44.4 (2019): 1594-1594.
Chicago
Tian, F., Zhan, Y., Zhu, W., Li, J., Tang, M., Chen, X., Jiang, J."[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2". International Journal of Molecular Medicine 44, no. 4 (2019): 1594-1594. https://doi.org/10.3892/ijmm.2019.4297